Vimarsana
Biggest News Aggregation in the World

Page 3 - Midatech Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Midatech Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Midatech Pharma Today - Breaking & Trending Today

Extended Release Injectable Drugs Research Report 2023: Formulation Technologies & Platforms, Physical Process Control Methods, Development Factors, Competitive Landscape - Vimarsana News

Extended Release Injectable Drugs Research Report 2023: Formulation Technologies & Platforms, Physical Process Control Methods, Development Factors, Competitive Landscape

/PRNewswire/ -- The "Extended Release Injectable Drugs" report has been added to ResearchAndMarkets.com's offering. Chronic conditions require drug...

Midatech Pharma : Biodexa Pharmaceuticals PLC?Annual Report 2022Biodexa Pharmaceuticals PLC(formerly Midatech Pharma Plc)Annual Report 2022 - Form 6-K - Vimarsana News

Midatech Pharma : Biodexa Pharmaceuticals PLC?Annual Report 2022Biodexa Pharmaceuticals PLC(formerly Midatech Pharma Plc)Annual Report 2022 - Form 6-K

Biodexa Pharmaceuticals PLC?Annual Report 2022Biodexa Pharmaceuticals PLCAnnual Report 2022 ... | June 1, 2023

Global Somatostatin Analogs Market to Reach $12.4 Billion - Vimarsana News

Global Somatostatin Analogs Market to Reach $12.4 Billion

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s...

Epsilogen announces significant expansion of management team with three new senior hires - Vimarsana News

Epsilogen announces significant expansion of management team with three new senior hires

L’AFP est une agence d’information globale, assurant une couverture rapide, complète et vérifiée des événements de l’actualité comme des thèmes qui façonnent notre quotidien. Avec un réseau de journalistes sans égal, déployé sur 151 pays, l'AFP est en outre un leader mondial de l’investigation nu...

Source: afp.com
Biodexa Pharmaceuticals (LON:MTPH) Share Price Crosses Above Fifty Day Moving Average of $4.18 - Vimarsana News

Biodexa Pharmaceuticals (LON:MTPH) Share Price Crosses Above Fifty Day Moving Average of $4.18

Biodexa Pharmaceuticals Plc (LON:MTPH – Get Rating) shares passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 4.18 ($0.05) and traded as high as GBX 20 ($0.25). Biodexa Pharmaceuticals shares last traded at GBX 18 ($0.22), with a volume of 73,672 shares […]